Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox

<p>Abstract</p> <p>Background</p> <p>Graft-versus-host disease is the single most important obstacle facing successful allogeneic stem cell transplantation (SCT). Even with current immunosuppressive therapies, morbidity and mortality rates are high. Current therapies in...

Full description

Bibliographic Details
Main Authors: Inayat Mohammed S, El-Amouri Ismail S, Bani-Ahmad Mohammad, Elford Howard L, Gallicchio Vincent S, Oakley Oliver R
Format: Article
Language:English
Published: BMC 2010-08-01
Series:Journal of Inflammation
Online Access:http://www.journal-inflammation.com/content/7/1/43